Cancer Research UK
Overview
Cancer Research UK is a non-profit organization that acts as a major investor in cancer research, providing early-stage capital and venture creation support to oncology ventures through its innovation arm, Cancer Research Horizons.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Boundless Bio | Jun 2022 | Grant | Co-investor |
| Accession Therapeutics Limited | Nov 2022 | Series A | Co-investor |
| Coherence Neuro | Aug 2022 | Grant | Co-investor |
| Yemaachi Biotechnology | Mar 2024 | Grant | Co-investor |
| MultiplAI Health | Nov 2021 | Accelerator | Co-investor |
For institutional investors. Book with your work email.
Key People
Beth Sitek
Co-Founder of The Sunflower Foundation
Carmela R.
Content Strategy Partner
Simon Boulton
Director, Cancer Research UK, RadNet - City of London
Amar S Ahmad
Principal Statistician
Andrew Rowan
Principal Scientific Officer
Jade Lyons Rimmer
Principal Medical Writer
Susan Minogue
Principal Clinical Data Manager
Chris Goddings
Senior Portfolio Manager
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cancer Research UK based?
Cancer Research UK is headquartered in London, United Kingdom.
When was Cancer Research UK founded?
Cancer Research UK was founded in 2002.
How many portfolio companies does Cancer Research UK have?
Cancer Research UK has 8 portfolio companies in Caplight's dataset.
What are some companies in Cancer Research UK's portfolio?
Portfolio companies visible on Caplight include Boundless Bio, Accession Therapeutics Limited, Coherence Neuro, Yemaachi Biotechnology, MultiplAI Health.
What was Cancer Research UK's most recent investment shown here?
Cancer Research UK's most recent investment in this portfolio sample was in Yemaachi Biotechnology in 2024.
What sectors does Cancer Research UK focus on?
Cancer Research UK focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Cancer Research UK focus on?
Cancer Research UK typically invests at the Early stage.
What is Cancer Research UK's AUM?
Cancer Research UK's assets under management are estimated between $500.0M and $1.0B.